| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/04/2012 | EP2400961A1 Drug combinations containing pde4 inhibitors and nsaids |
| 01/04/2012 | EP2400959A1 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity |
| 01/04/2012 | EP2400851A1 Composition and drug delivery of bisphosphonates |
| 01/04/2012 | EP2310389B1 Heterocycles as protein kinase inhibitors |
| 01/04/2012 | EP2300482B1 ANNELLATED 4-(INDAZOLYL)-1,4-DIHYDROPYRIDINE DERIVATIVES AS c-Met MEDIATORS |
| 01/04/2012 | EP2297148B1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 01/04/2012 | EP2297103B1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors |
| 01/04/2012 | EP2056829B1 Using pi3k and mek modulators in treatments of cancer |
| 01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/04/2012 | EP1877366B1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity |
| 01/04/2012 | EP1494649B1 Nanoparticulate megestrol formulations |
| 01/04/2012 | EP1422225B1 Benzoisoselenazole derivatives with anti-inflammation, antineoplastic and anti-thrombosis activity and their use |
| 01/04/2012 | EP0914142B9 Peptides with increased binding affinity for at least three hla-a3-like molecules |
| 01/04/2012 | CN102307989A Method for producing dendritic cells |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307891A WDRPUH epitope peptides and vaccines containing the same |
| 01/04/2012 | CN102307881A Tripolide C-ring derivatives as anticancer agents and immune modulators |
| 01/04/2012 | CN102307875A Pyrrolopyrimidinyl axl kinase inhibitors |
| 01/04/2012 | CN102307872A BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
| 01/04/2012 | CN102307869A Aminopyrazine derivative and medicine |
| 01/04/2012 | CN102307868A Indole derivatives as anticancer agents |
| 01/04/2012 | CN102307862A Compounds for treating cancer |
| 01/04/2012 | CN102307852A Cyclic amine compounds |
| 01/04/2012 | CN102307847A Indanyl compounds |
| 01/04/2012 | CN102307842A Plant extracts from acronychia species and their use |
| 01/04/2012 | CN102307622A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/04/2012 | CN102307569A Pharmaceutical compositions comprising imidazoquinolin (amines) and derivatives thereof suitable for local administration |
| 01/04/2012 | CN102304555A Preparation method and application of antibiotics lobophorin A and lobophorin B |
| 01/04/2012 | CN102304538A Construction and screening as well as applications for siRNAs expression carrier of stomach cancer target STAT3 gene |
| 01/04/2012 | CN102304184A Neuropilin antagonists |
| 01/04/2012 | CN102304179A GLP-1 and exendin related invention |
| 01/04/2012 | CN102304178A Preparation method and application of African clawed toad antitumor polypeptide |
| 01/04/2012 | CN102304132A High-efficiency high-stereoselectivity semisynthesis method of harringtonine and allied alkaloids |
| 01/04/2012 | CN102304128A Heterocyclic naphthalimide derivative as well as preparation method and application thereof |
| 01/04/2012 | CN102304110A Hydroxamates as therapeutic agents |
| 01/04/2012 | CN102304091A Emodin and fluorouracil combined compound having antitumor activity and preparation method thereof |
| 01/04/2012 | CN102304086A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/04/2012 | CN102304047A Gamma-hydroxy olic acid ester derivatives and use thereof in preparation of antitumor medicines |
| 01/04/2012 | CN102302788A Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 01/04/2012 | CN102302786A Preparation method for beta-cyclodextrin polymer-paclitaxel inclusion compound |
| 01/04/2012 | CN102302785A Preparation method of water-soluble hypericin supramolecular inclusion compound |
| 01/04/2012 | CN102302784A Tumor chemotherapeutic medicinal preparation and preparation method thereof |
| 01/04/2012 | CN102302783A Bufalin-loaded cyclic peptide-modified polyethylene glycol-polylactic acid hydroxyl glycolic acid-polylysine nanoparticles |
| 01/04/2012 | CN102302782A Preparation method of hepatoma carcinoma cell-targeted polyamido-amine dendrimer support |
| 01/04/2012 | CN102302742A Traditional Chinese medicine composition for treating cardiac cancer and esophageal cancer |
| 01/04/2012 | CN102302737A Traditional Chinese medicine composition for treating gastric cancer |
| 01/04/2012 | CN102302733A Oral Chinese medicinal composition for treating ovarian cyst |
| 01/04/2012 | CN102302719A Medicament for treating tumor |
| 01/04/2012 | CN102302718A Antitumor medicinal composition and preparation method thereof |
| 01/04/2012 | CN102302714A Traditional Chinese medicine for treating primary lung cancer |
| 01/04/2012 | CN102302663A Chinese medicine for treating primary carcinoma of liver |
| 01/04/2012 | CN102302649A Traditional Chinese medicine composition for treating hysteromyoma |
| 01/04/2012 | CN102302621A Chinese herbal medicine for treating liver cancers |
| 01/04/2012 | CN102302612A Preparation method for tea polyphenols and nanofiltration device |
| 01/04/2012 | CN102302586A Extraction method of total iridoid glycoside from hedyotis diffusa willd |
| 01/04/2012 | CN102302567A Stagnation-removing and stasis-removing Chinese patent medicine |
| 01/04/2012 | CN102302561A Method for preparing belvedere fruit total saponins |
| 01/04/2012 | CN102302556A Extraction method of total flavonoid from coriaria sinica maxim |
| 01/04/2012 | CN102302554A Extraction method of schisandra total lignans |
| 01/04/2012 | CN102302553A Extraction method of key components of Chinese magnoliavine fruit medicament |
| 01/04/2012 | CN102302542A Chinese medicinal oral liquid for treating cancers |
| 01/04/2012 | CN102302539A Method for producing trifolium pratense L. isoflavones |
| 01/04/2012 | CN102302532A Extraction technologcial method of glucosinolate in canola meal |
| 01/04/2012 | CN102302529A Purple ginseng prepared by vaccinium fermentation method and application thereof in medicine |
| 01/04/2012 | CN102302526A Preparation method and application of macaranga tanarius extract |
| 01/04/2012 | CN102302507A Medicinal composition for directional controlled release of trace elements and preparation method and application |
| 01/04/2012 | CN102302503A Preparation method for daunorubicin and 5-bromotetrandrine co-carried magnetic ferrosoferric oxide nanoparticles |
| 01/04/2012 | CN102302500A Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 01/04/2012 | CN102302499A Capsule preparation containing tegafur, gimeracil and potassium oxonate |
| 01/04/2012 | CN102302496A Applications of isoquinoline-type alkaloid and derivatives thereof in preparing medicaments for preventing or treating cervical cancer |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302493A Methods to mobilize progenitor/stem cells |
| 01/04/2012 | CN102302492A Methods and compositions for the treatment of neuropathic pain |
| 01/04/2012 | CN102302491A Application of sorafenib to treatment of cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) |
| 01/04/2012 | CN102302488A Applications of compound aiming at CCL18 target in preparing breast cancer resistant medicaments |
| 01/04/2012 | CN102302483A Application of flavonoid small molecule medicine in anti-inflammation and associated diseases |
| 01/04/2012 | CN102302482A Morin-7-sodium sulfate for inhibiting enzymatic activity of PRL-3 (phosphatase of regenerating liver-3) and application of morin-7- sodium sulfate in medicines for resisting tumor metastasis |
| 01/04/2012 | CN102302477A Cinobufagin dry power inhaler and preparation method and application thereof |
| 01/04/2012 | CN102302476A Dehydrobufotenine dry power inhaler and preparation method and application thereof |
| 01/04/2012 | CN102302475A Resibufogenin dry powder inhalant and preparation method and application thereof |
| 01/04/2012 | CN102302473A Matrine magnetic slow-releasing capsule and preparation method |
| 01/04/2012 | CN102302466A Capecitabine medicinal composition capable of direct powder tableting, and application thereof |
| 01/04/2012 | CN102302464A Imatinib mesylate tablet |
| 01/04/2012 | CN102302462A Gemcitabine hydrochloride lyophilized preparation |
| 01/04/2012 | CN102302460A Methylprednisolone sodium succinate freeze dried powder injection and preparation method thereof |
| 01/04/2012 | CN102302459A Preparation method of drug carried microsphere capable of being positioning injected into tumor cavity |
| 01/04/2012 | CN102302451A Honokiol submicroemulsion injection and production method thereof |
| 01/04/2012 | CN102302450A Hydrophobic drug-albumin-glucan nano emulsion, as well as preparation method and application thereof |
| 01/04/2012 | CN102302447A Novel taxol lipid microsphere injection and preparation method thereof |
| 01/04/2012 | CN102302444A Genistein injection and preparation method thereof |
| 01/04/2012 | CN102106928B Method for preparing high-purity oil tea saponins |
| 01/04/2012 | CN102018864B Traditional Chinese medicine for curing esophagus cancer and processing method of traditional Chinese medicine |
| 01/04/2012 | CN101940792B PCL-b-PEG-b-PCL carried hydrophobic medicine polymer vesica as well as preparation method and application thereof |
| 01/04/2012 | CN101920017B Composite for promoting glycyrrhetinic acid to realize percutaneous permeation |
| 01/04/2012 | CN101831461B Human small RNA-148a expression vector and use thereof |
| 01/04/2012 | CN101829053B Preparation method of gossypol acetate intravenous injection fatty emulsion |
| 01/04/2012 | CN101822839B Preparation of nanometer structure lipid carrier by using seal oil as liquid-phase substrate and application |
| 01/04/2012 | CN101735193B 9-anthranone spiro lactone compound and preparation method and application thereof |